January 16, 2018 / 1:54 PM / Updated 8 minutes ago BRIEF-Mimedx Announces First Patients Have Been Enrolled In The Phase 3 Clinical Trial Of Amniofix Reuters Staff 1 Min Read 
Jan 16 (Reuters) - Mimedx Group Inc: 
* MIMEDX ANNOUNCES FIRST PATIENTS HAVE BEEN ENROLLED IN THE PHASE 3 CLINICAL TRIAL OF AMNIOFIX® INJECTABLE IN PATIENTS WITH RECALCITRANT PLANTAR FASCIITIS PAIN 
* MIMEDX GROUP INC - ‍COMPANY PROJECTS FILING OF BLA RELATED TO PLANTAR FASCIITIS WILL BE IN 2020​ Source text for Eikon: Further company coverage: